Fentanyl Patch

Fentanyl Patch
Product Description

Fentanyl is a synthetic analgesic related to phenylpiperidines, which interacts predominately with the opioid μ-receptor. Fentanyl primary actions are analgesia and sedation. Minimum effective analgesic serum concentrations of fentanyl in opioid naive patients range from 0.2 to 1.2 ng/mL, and side effects increase in frequency at serum levels above 2 ng/mL. Both the minimum effective concentration and the concentration at which toxicity occur rise with increasing tolerance.Fentanyl is estimated to be 80 times as potent as morphine as an analgesic. At therapeutic dosages, fentanyl usually does not exert major effects on the cardiovascular system. Respiratory-depressant effect of fentanyl is of shorter duration than that of meperidine. In non-opioid-tolerant patients the risk of hypoventilation increases at serum fentanyl concentrations greater than 2 ng/mL, especially for those who have an underlying pulmonary condition.As with other dru...

Amarin Technologies SA

  • AR
  • 2019
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    The Transdermal Delivery System (TDS) for Fentanyl developed by AMARIN is a drug-in-adhesive monolithic-type device, transparent and thin, with a bilayer matrix design, which has proved to be bioequivalent to Durogesic® SMAT (matrix-type device form Jannsen Pharmaceutica).
  • Model
    Transdermal Patch

Amarin Technologies SA

  • AR
  • 2019
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Service
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)

More Products from Amarin Technologies SA (2)

  • Buprenorphine Patch

    Product Buprenorphine Patch

    Amarin has developed a patch intended to be AB rated to Butrans®, but with the comparative advantages of having half of the drug content and also a reduced size (having less residual drug after 7 days of use). As the patch delivers the same amount of drug, this makes it more efficient.

    O...
  • Methylphenidate Patch

    Product Methylphenidate Patch

    Amarin patch is 33% smaller ant it also has one third less of the drug content. As the patch delivers the same amount of drug, this makes it 149% more efficient in comparison to the originator.

     Additionally, there has been multiple customers complains on Dyatrana due to backing ...

Amarin Technologies SA resources (1)